CClinicalTrials.gg
Status unknownNCT05348551TLS-DIDUpdated Apr 27, 2022

Overview of Telemedicine in Children With Type 1 Diabetes

An observational study in Telemedicine, Diabetes Mellitus, Type 1 and Children, Only, sponsored by University Hospital, Grenoble. Status unknown. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2022-04-27.

Sponsored by University Hospital, Grenoble · Observational

The sponsor has not verified this record recently (last verified Apr 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
4,800
Ages
Up to 17 Years
Sex
All
01

Study summary

Assessment of the proportion of pediatric patients with type 1 diabetes with access to remote monitoring

Read the detailed description

In the follow-up of type 1 diabetes in children, contact with families besides the appointements with medical et paramedic staff (paediatrician, diabetologist, nurses) is very common but not well coded, start from telehealth hubs (like myDiabby), to less unofficial contact by phone or email. This is even more so widespread since generalization of continuous glucometer (freestyle, dexcom,...), which allowed a quick data transfer to the medical staff.

Some studies had shown that telemedicine in diabetes allowed a better glycemic control and a higher implication in the desease. Indeed, in 1999 already, HbA1c significant improvement was shown when patients was regularly called by a nurse (Thompson et al.). Same finding was demonstrated in Schiaffini and al. clinical trial in 2016. This trial also shown a better adhesion to the follow up into the telemedicine group. Despite all of this studies, in France, remote monitoring isn't standardised and financed, except the national experimentation ETAPES which promotes and financially supports the deployment of remote monitoring projects around the territory.

02

Conditions studied

  • Telemedicine
  • Diabetes Mellitus, Type 1
  • Children, Only

Keywords

  • Diabetes mellitus type 1
  • Children
  • Telemedicine
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's planned enrollment of 4,800 is above the median of 233 across 2,220 observational studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

University Hospital, Grenoble is the lead sponsor of 815 studies on the registry; 205 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children aged 0 to 17 years with type 1 diabetes

Inclusion criteria

  • Children with type 1 diabetes

Exclusion criteria

Exclusion Criteria:

  • No consent
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
4,800 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Assessment of the proportion of pediatric patients with access to remote monitoring

    Proportion of pediatric patients with access to remote monitoring

    Time frame: 1 day

Secondary outcomes

  1. Description of the different means and modalities of remote monitoring for patients

    Proportion of patients in the different modalities of remote monitoring

    Time frame: 1 day

  2. Description of the different means and modalities of remote monitoring for patients

    Proportion of patients in the different objectives of remote monitoring

    Time frame: 1 day

  3. Evaluation of patients' (and parents') perception of telemonitoring using a scale

    Perceived importance of this remote monitoring score using a scale from 1 (mean no importance, I could do without) to 10 (mean it's very important, I think it's essential)

    Time frame: 1 day

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05348551
Lead sponsor
University Hospital, Grenoble
Responsible party
Sponsor
First posted
Apr 27, 2022
Start date
May 20, 2022 (estimated)
Primary completion
Jul 20, 2022 (estimated)
Completion
Jul 20, 2022 (estimated)
Last update
Apr 27, 2022

Study contacts

Clémentine DUPUIS
Contact
cdupuis2@chu-grenoble.fr
0476760924
Clémentine DUPUIS
principal investigator · University Hospital, Grenoble

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion